Sun Pharma Board Approves Promoter Reclassification and Adopts Revised Code of Fair Disclosure

Sun Pharma Board Approves Promoter Reclassification and Adopts Revised Code of Fair Disclosure

Sun Pharma Board Approves Promoter Reclassification and Adopts Revised Code of Fair Disclosure​

Sun Pharmaceutical Industries Limited announced key outcomes from its Board of Directors meeting held on May 22, 2026. During the session, the Board approved requests regarding promoter group reclassification and adopted a revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.

The Board formally approved the requests received for the reclassification of certain promoter group individuals from the 'Promoter Group' category to the 'Public' category. This decision furthered the details provided in an earlier communication dated May 14, 2026.

In addition, the company's Board approved and adopted the revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. The new Code is scheduled to become effective starting June 1, 2026.

Regarding the proceedings, the Board Meeting commenced at 10:45 AM. The session was subsequently resumed and concluded at 4:00 PM.

SUNPHARMA Stock Price Movement​

On Friday, Sun Pharmaceutical Industries Limited shares slipped by 2.71% to settle at ₹1844.6. The equity closed off the day after having hit its 52-week high at ₹1916.6, trading on a volume of 3.61 million shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top